Rare diseases
Investigational molecules
Locations
Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery
FranceStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
FranceStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
FranceStudy of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer
FranceStudy on Preserving the Voice Box in Patients with Advanced Laryngeal or Hypopharyngeal Cancer Using Cisplatin, Fluorouracil, and Docetaxel Therapy
FranceStudy on Early Temozolomide Treatment for Adults with Glioblastoma
FranceStudy on the Effects of Methylprednisolone and Sodium Chloride in Patients Undergoing Surgery for Digestive Cancer
FranceStudy on the Effects of Etavopivat for Patients Aged 12-65 with Sickle Cell Disease
FranceStudy of Lecanemab (BAN2401) Treatment in People with Early Alzheimer's Disease: Testing Safety and Effectiveness Over 18 Months
FranceStudy on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes
FranceStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
FranceStudy on the Effectiveness of Mesenchymal Stromal Cells in Children with Steroid-Refractory Acute Graft-Versus-Host Disease
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
